Abstract: Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive peripheral T-cell lymphoma (PTCL) of follicular helper T-cell origin and is rare in Taiwan. There are overlapping features of AITL and peripheral T-cell lymphoma with a follicular growth pattern (PTCL-F). Around one fifth of PTCL-F exhibits t (5; 9) (q33; q22)/ITK-SYK chromosomal translocation, which is essentially absent in AITL. We retrospectively investigated 35 cases of AITL from Taiwan with histopathology review, immunohistochemistry, in situ hybridization for Epstein-Barr virus (EBV) and fluorescence in situ hybridization (FISH) for t(5;9)(q33;q22)/ITK-SYK and correlated the results with overall survival. Twenty-six cases of not otherwise specified PTCL (PTCL-NOS) were also examined by FISH for comparison. Most AITL patients were male (69%) and elderly (median age at 67 years) with frequent bone marrow involvement (53%), high Ann Arbor stages (77%), and elevated serum lactate dehydrogenase (68%). Most cases (80%) showed a typical CD4+/ CD8-phenotype and in 90% cases there were scattered EBV-positive B-cells (less than 10% cells). None of these cases showed t(5;9)(q33;q22)/ITK-SYK translocation by FISH. Gain of ITK and SYK gene was identified in 38% and 14% tumors, respectively, but both were not associated with overall survival. Performance status < 2 was associated with a better outcome but not the other clinicopathological factors. All PTCL-NOS cases were negative for ITK-SYK translocation with similar rates (38% and 12%, respectively) of gains at ITK and SYK loci as that of AITL. In this so far the largest series of AITL from Taiwan, we reported the clinicopathological features and FISH findings on ITK and SYK genes. We confirmed the absence of t(5;9)(q33;q22)/ITK-SYK translocation, which may serve as an additional differential diagnostic tool from PTCL-F when present. PTCL-NOS shared a similar pattern of ITK and SYK gains with AITL. More studies are warranted to elucidate the roles of SYK and ITK and other genes in the lymphomagenesis of AITL in Taiwan.
Introduction
Angioimmunoblastic T-cell lymphoma (AITL), a nodal peripheral T-cell lymphoma (PTCL), is characterized by a systemic disease and polymorphous infiltration with proliferation of high endothelial venules and hyperplasia of the follicular dendritic meshworks [1] . AITL affects mostly elderly patients and the patients frequently present with generalized lymphadenopathy, hepatosplenomegaly, systemic manifestations (such as B symptoms), skin rashes, and polyclonal hypergammaglobulinemia. Immune disorders such as circulating immune complex and hemolytic anemia are not uncommon. The tumor cells of AITL originate from follicular helper T-cells (T FH ) in the germinal centers [2] and characteristically express several T FH markers including chemokine CXCL13, cell-surface molecules PD-1/CD279, ICOS and CD200, the adaptor molecule SAP, and the transcription factors Bcl-6 and c-Maf [3] [4] [5] [6] [7] [8] . The prognosis of AITL is dismal, with a median survival of less than three years [1] .
Follicular variant of peripheral T-cell lymphoma (PTCL-F) is a subtype of PTCL with a follicular growth pattern. PTCL-F resembles AITL both histologically and immunophenotypically with a T FH immunophenotypic profile. Furthermore, both diseases may present synchronously or metachronously in the same patient, suggesting a close relationship [9] . Interleukin 2-inducible T-cell kinase (ITK) gene on chromosome 5 encodes for a tyrosine kinase and plays an important role in T-cell proliferation and differentiation. Chromosomal translocation t(5;9) (q33;q22) involving ITK gene and the spleen tyrosine kinase (SYK) gene on chromosome 9 has been reported in around one fifth of patients with PTCL-F but is extremely rare in AITL [9] [10] [11] [12] .
In our previous studies, the frequency of AITL among lymphomas in Taiwan increased from 0.5% in the period of 1989-1998 to 3% during [2005] [2006] [2007] , while the relative frequency of T-cell lymphomas among non-Hodgkin lymphoma remained stationary at 18% [13] [14] [15] . Recently, Lin et al. investigated 31 cases of AITL from Taiwan and found that the initial presentation with fever, advanced stage, and failure to achieve complete remission (CR) were independent adverse factors for overall survival (OS) with multivariate analysis [16] . To date, there is no molecular study on the alteration of ITK and SYK genes on AITLs from Taiwan. In this retrospective study we investigated the clinicopathological features, Epstein-Barr virus (EBV) status, and possible roles of ITK and SYK genes in this so far the largest series of AITL from Taiwan.
Materials and methods

Patients
We searched the lymphoma database for cases of AITL and not otherwise specified PTCL (PTCL-NOS) at Chi-Mei Medical Center, Tainan, Taiwan from 1998 to 2010. All lymphoma cases were diagnosed and classified according to the World Health Organization (WHO) criteria [1] . This study was approved by the Institutional Review Board of Chi-Mei Medical Center.
Histopathology and immunophenotyping
The original and newly cut HE sections of all cases were reviewed and the diagnosis confirmed by at least two of us (P.-I.L. S.-T.C, and S.-S.C). For immunohistochemistry, formalinfixed paraffin embedded (FFPE) sections of 4 µm thickness were used with the labeled streptavidin-biotin peroxidase method (Super Sensitive TM Link-Label HRP Detection Systems, BioGenex Laboratories, San Ramon, CA., U.S.A.) and an antigen-retrieval technique was applied as needed for each antibody. The antibodies used were CD3, CD8, CD20, bcl-6, Ki67 (DakoCytomation, Glostrup, Denmark), CD4, CD5, CD10 (Novocastra, Newcastle upon Tyne, U.K.), bcl-2, bcl-6, and IRF4/MUM1 (DakoCytomation, Glostrup, Denmark), and PD-1 (Cell Marque, Uden, The Netherlands). Appropriate positive controls were used in all stains.
In-situ hybridization for EBV
We performed in situ hybridization for EBVencoded mRNA (EBER) in an autostainer (Bond MAX, Vision BioSystems Ltd., Mount Waverley, Australia) using a polymer-based detection system (Bond TM Polymer Refine Detection, Vision BioSystems Ltd.) with an EBV specific probe (Bond TM ISH EBER Probe) and 3, 3'-Diaminobenzidine (DAB) as chromogen.
Fluorescence in situ hybridization (FISH)
We selected the following bacterial artificial clones for identifying ITK-SYK rearrangements: RP11-563G12 and RP11-51G20 flanking SYK for SYK translocations, RP11-31B18 and RP11-47O12 flanking ITK for ITK translocations. We directly labeled the probes with Spectrum Ora-
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Int J Clin Exp Pathol 2014;7(9):6097-6107 nge and Spectrum Green-dUTP using nick translation (Vysis/Abbott Laboratories Ltd., Maidenhead, UK.). FISH study was performed on deparaffinized FFPE sections of 4 µm thickness as previously described [17] . Co-localization of the orange and green signals in over 10% cells examined were considered as presence of t (5; 9) (q33; q22)-ITK/SYK translocation. Gain of ITK and SYK genes was defined as equal to or greater than 3 signals (copies) in over 10% cells examined.
Statistical analysis
Medical records of the patients were reviewed. OS was measured from the date of diagnosis to the date of last follow-up or death. Categorical data were described by counts and percentages and were compared by using Fisher's exact test. Continuous variables with skewed distribution were described by median and interquartile range; comparisons of them were performed by Mann-Whitney U test. Kaplan-Meier survival curves were drawn and log rank test was used to compare the difference between survival curves. Univariate and multivariate Cox proportional hazard regression analyses were also performed to get the crude and the adjusted hazard ratio of demographic and clinicopathological factors for survival. Data analyses were done by using SPSS for Windows, version 17.0 (SPSS Inc., Illinois, U.S.A.). P values less than 0.05 were considered statistically significant.
Results
Patients and clinical features
We identified 35 AITL cases including 25 inhouse (Cases no. 1-25) and 10 consultation cases (Cases no. 26-35; to S.-S.C.). Table 1 summarizes the pertinent histopathological and immunophenotypic findings with a representative case in Figure 1 . Histopathologically, pattern 1 morphology was present in only 2 (5%) cases, while patterns 2 and 3 accounted for 12 (34%) and 21 (60%) cases, respectively. B-cell proliferation, characterized by the presence of sheets of large B lymphocytes, was observed in 15 (43%) cases; none was diagnosed as concurrent large B-cell lymphoma. B-cell proliferation was more frequently associated with cases with patterns 1 or 2 than with pattern 3 (64% vs. 29%, P = 0.036). Immunohistochemically, 26 (81%) of 32 cases showed the typical CD4-positive CD8-negative phenotype. Cases without the typical CD4/CD8 phenotype were seen in pattern 3 tumors but not in patterns 1 or 2 (p = 0.02). CD10 expression was observed in 19 (54%) cases. Interestingly, 6 of the 16 CD10-negative cases that stained for PD-1 were all positive. The Ki-67 labeling indices of these cases ranged from 10% to 70%, with a median and a mean value of 50% and 45%, respectively.
Histopathology and immunohistochemistry (IHC) study
EBER study
EBER study was performed in 30 cases. In six (20%) cases EBER-positive signals accounted for less than 1% cells. In 21 (70%) and 3 cases, EBER positive cells accounted for 1-10% and 
Fluorescence in situ hybridization (FISH) study
FISH study for t(5;9)(q33;q22)-ITK/SYK translocation were successfully performed in all AITL cases, which were all negative for t(5;9) (q33;q22)-ITK/SYK translocation. Gain of ITK and SYK gene was observed in 37% (13 of 35 cases), and 14% (5 of 35 cases), respectively ( Figure 2) . Cases with gain of SYK gene was more frequently seen in those with concurrent gain of ITK gene (45% vs. 80%, P = 0.037) and only in those with pattern 3 but not in patterns 1 or 2 (P = 0.043). Gain of ITK gene was more frequently observed in female patients (64% vs. 25%, P = 0.028).
A total of 26 cases of PTCL-NOS were randomly selected for comparison. FISH study for t(5;9) (q33;q22)-ITK/SYK translocation were successfully performed in all PTCL-NOS cases. All cases were negative for t(5;9) translocation. Gains of ITK and SYK were noted in 38% (10/26) and 12% (3/26) cases, respectively, nearly at the same rates as that of the AITL cases.
Survival analysis
Univariate analysis (Table 2) showed that performance status equal to or less than 1 at the diagnosis correlated with better OS (P < 0.001).
Other clinicopathological factors, including histological patterns (patterns 1 or 2 vs. pattern 3), presence of a B-cell proliferation, CD4 vs. CD8 immunoprofile, Ki-67 labeling index, and EBV status were not statistically significant. Gain of either ITK or SYK genes was not associated with OS (P = 0.736 and 0.428, respectively).
Discussion
We reported the clinicopathological and FISH findings in this so far the largest series of AITL from Taiwan. The clinicopathological features including old age, male predominance, a T FH phenotype, and a poor prognosis were in agreement with prior studies. We identified PS score as an important prognostic factor in OS. Furthermore, we confirmed the previous study that AITL was negative for t(5;9)(q33;q22)-ITK/ SYK translocation [9] [10] [11] [12] . Instead we found that 38% and 14% of the AITL cases exhibited gains of ITK and SYK genes, respectively. Interestingly such genetic alterations occurred nearly at the same rate in our cohort of 26 examples of PTCL-NOS, suggesting that these two diseases our data, mainly cases from southern Taiwan, were essentially the same as that study in terms of male predominance (2.2:1 vs. 2.1:1), high-stage disease (68% vs. 63%), elevated LDH (68% vs. 63%) and 2-yr survival (40% vs. 39%), except that our patients were slightly less elderly (mean age at 67 vs. 74 years).
PTCL-F, a variant of PTCL-NOS in the WHO classification, is characterized by neoplastic T-cells localized within the germinal centers, distributed within the marginal zone with a perifollicular distribution, or confined in the expanded mantle zones of the follicles [21] . PTCL-F closely resembles AITL histologically, and shares a similar T FH -immunoprofile. Furthermore, both diseases may occur synchronously or metachronously in the same patient, indicating a close relationship. In contrast to AITL in which t(5;9)(q33;q22)-ITK/SYK translocation is extremely rare, one fifth of PTCL-F cases exhibit this translocation. However, recently Attygalle et al. demonstrated an exceptional AITL case may share some common genetic features. However, such genetic alterations were not associated with OS in our cohort of AITL patients.
Although the relative frequency of T and NK/T-lymphoma in Taiwan, up to 18% among nonHodgkin lymphoma, is higher than that in the West, AI-TL is rare and comprises only 0.5 to 2.4% of all lymphoma cases in various institutes [13, 14, 16, [18] [19] [20] . The clinical features of this lymphoma have not been characterized until recently by Lin et al. who reported a retrospective study of 31 patients from northern Taiwan [16] . Interestingly, exhibiting t(5;9)(q33;q22)-ITK/SYK translocation, providing an additional link between these two lymphoma types [12] . In our study, no such translocation was identified, either in the 35 cases of AITL or 26 cases of PTCL-NOS. Although the frequency of this translocation is not high in PTCL-F, its presence may serve as a surrogate favoring PTCL-F when the differential is AITL.
The growth patterns of AITL have been classified into 1, 2, or 3, representing those with hyperplastic, regressed or effaced germinal centers, respectively [22] . Pattern 1 is rarely seen and mimics a reactive process, thus is easily misdiagnosed as reactive lymphoid hyperplasia. Very recently, Tan et al. compared 30 cases each of pattern 1 AITL and reactive lymphoid hyperplasia from Singapore and found that the former patients were older, more frequently non-Chinese and with nodal presentation. The former could be distinguished from the latter by an aberrant immunoarchitecture [23] . In addition, AITL patients with pattern 1 morphology had a better OS than those with pattern 2 [24] . With disease progression, tumors with pattern 1 morphology may evolve to pattern 3 with an interval ranging from 2 to 168 months [22] . Noteworthy, secondary lymphomas such as classic Hodgkin lymphoma and diffuse large B-cell lymphoma may complicate tumors with patterns 2/3 morphology but not pattern 1 [22] . In our series, there were only two cases (Case no. 10 and 26) with pattern 1 morphology and the case number was too small for comparison with those with other patterns. Our Case no. 10 was initially mis-diagnosed as reactive hyperplasia and was included as one of the cases in the study of histological evolution of AITL by Attygalle et al. (Case no. 2 in that series) [22] . Misdiagnosis of AITL is not infrequent, especially by general pathologists inexperienced in hematopathology. Tan et al. observed a 48% discordant rate, occurring more frequent in those with pattern 1 (4 out of 7 cases) morphology than pattern 3 (7 out of 17 cases). Pathologists should pay particular attention to nodal lesions with atypical morphological features of germinal centers and take into account the clinical context, particularly for elderly patients with generalized lymphadenopathy, B symptoms and elevated LDH to avoid misdiagnosis, especially those with AITL of pattern 1 morphology.
The poor outcome of patients with AITL may be due to a high frequency of advanced disease at diagnosis, old age, and frequent presence of infectious complications; all these factors render these patients unsuitable for chemotherapy with curative intent. From the observation of 157 patients in the GELA trial, Mourad el al. showed that male patients, anemia (Hb < 120 g/dL), and presence of mediastinal lymphadenopathy were factors adversely affecting the overall survival of patients with AITL [25] . In recent years, gene expression profiling indicated T FH origin of AITL and revealed substantial components of the molecular signature of AITL are contributed by the follicular dendritic cells, B-cell, and other stromal components [26] [27] [28] . Accordingly, Iqbal et al. constructed a molecular prognosticator for AITL that appears to be largely related to the microenvironmental signature [28] . They subsequently applied their molecular classifier for AITL and were able to reclassify 14% of PTCL-NOS as AITL, which were initially not pathologically diagnosed as AITL because of the absence of certain key morphologic or immunohistochemical features. They found that in AITL, high expression of several signatures associated with the tumor microenvironment was significantly associated with outcome and a combined prognostic score was predictive of survival in an independent cohort [29] . Future studies on AITL may aim at reversing the immunosuppressive microenvironment to promote antitumor immunity and the suppression of the proliferation of EBV-transformed B cells [29] .
There were some limitations of our study, including a relatively small number of cases, a long study period that spanning 13 years, and a proportion of the patients with incomplete clinical data, particularly the consultation cases, and heterogeneous treatment modality. All these factors made the evaluation of treatment effect and the evaluation of various prognosticators difficult. Nonetheless, this is the largest series of AITL patients from Taiwan and we characterized the clinicopathological features and genetic alterations of ITK and SYK in this rare lymphoma. Future national and prospective studies with a homogeneous treatment modality are warranted.
